Amitiza is a brand-name prescription drug used for the treatment of chronic idiopathic constipation (CIC), opioid-induced constipation (OIC), and irritable bowel syndrome with constipation (IBS-C). The active ingredient in Amitiza, lubiprostone, increases fluid secretion from the intestinal lining. The additional water speeds up the movement of stools through the colon, increasing the number of spontaneous bowel movements. Amitiza is taken as a capsule with food and water twice a day.
RELATED: What is Amitiza? | Get Amitiza discounts
Amitiza is available in only one dosage form, gelatin-coated capsules.
Capsules: 8 micrograms (mcg), 24 mcg
For reference, a microgram is one-millionth of a gram, so each dose of Amitiza is very tiny. The capsule itself mainly consists of gelatin, water, and fats.
Amitiza capsules can be distinguished by their color. Both have “SPI” written on them, but the 8 mcg capsules are pink and the 24 mcg capsules are orange.
Amitiza is FDA-approved to improve bowel motility and the frequency of spontaneous bowel movements in adults with chronic idiopathic constipation, opioid-induced constipation, and irritable bowel syndrome with constipation (IBS-C).
| Amitza dosage chart | |||
|---|---|---|---|
| Indication | Starting dosage | Standard dosage | Maximum dosage |
| Chronic idiopathic constipation | 24 mcg capsule taken twice per day | 24 mcg capsule taken twice per day | 48 mcg per day |
| Opioid-induced constipation | 24 mcg capsule taken twice per day | 24 mcg capsule taken twice per day | 48 mcg per day |
| Irritable bowel syndrome with constipation | 8 mcg capsule taken twice per day | 8 mcg capsule taken twice per day | 16 mcg per day |
Constipation is a medical condition in which bowel movements are difficult and infrequent. Symptoms include irregular bowel movements, straining, hard stools, bloating, and abdominal discomfort. Chronic idiopathic constipation is diagnosed when people experience constipation symptoms for three months or more without any identifiable cause. Also called functional constipation, CIC is believed to result from improper functioning of the colon. This condition affects about 10% to 15% of adults during their lifetime.
Lubiprostone, the active ingredient in Amitiza, belongs to a family of drugs called prosecretory agents, that is, drugs that stimulate the colon tissues to secrete more fluids into the colon. Its mechanism of action is to activate pumps in the membranes of cells lining the intestinal walls. These pumps are called chloride channels, so lubiprostone is also called a “chloride channel activator.” When chloride channels are activated, the cells pump out water and chlorine ions into the colon. The increased fluid secretion improves intestinal motility and, as a result, increases the movement of stools through the colon. The more rapid movement of stools through the colon increases the daily number of spontaneous bowel movements, helping to relieve the symptoms of CIC.
Standard dosage for chronic idiopathic constipation: 24 mcg taken twice daily
Maximum dosage for chronic idiopathic constipation: 48 mcg per day
Amitiza is also FDA-approved to treat constipation due to opioid treatment for chronic noncancer pain. Amitiza can be used in people taking opioids for chronic pain due to previous cancer, but only if they don’t need regular increases in their opioid doses.
Opioids frequently cause constipation as part of a larger medical condition called opioid bowel dysfunction. To relieve pain, opioids attach to opioid receptors in the brain. However, the intestinal lining also has opioid receptors. When opioids attach to intestinal opioid receptors, they relax colon muscles and reduce the secretion of water into the colon. Stools become hard and move more slowly through the colon. Although the body quickly develops a tolerance for opioids as pain relievers, the gut does not develop tolerance
for constipation side effects, so opioid-induced constipation does not get better until the opioids are discontinued. As with CIC, Amitiza speeds up the movement of stools through the colon by stimulating the intestinal lining to secrete more fluids into the colon.
Standard dosage for opioid-induced constipation: 24 mcg taken twice daily
Maximum dosage for opioid-induced constipation: 48 mcg per day
Amitiza is also FDA approved to treat adult women with irritable bowel syndrome with constipation, also called constipation-predominant irritable bowel syndrome. IBS is a common gut problem that affects 9% to 23% of the population and is characterized by a host of symptoms including abdominal pain, diarrhea, and constipation. As with CIC, there is usually no identifiable cause, so IBS
is considered a functional gastrointestinal disorder (FGID). Amitiza increases fluid secretion into the colon, stimulating the colon to push its contents faster through the gut and increasing spontaneous bowel movements.
Standard dosage for IBS-C: 8 mcg taken twice daily
Maximum dosage for IBS-C: 16 mcg per day
Amitiza is only approved for adults 18 years of age and older. Its safety and effectiveness have not been studied in children or teens.
Lubiprostone does not enter the bloodstream in detectable amounts. However, it’s broken down into a metabolite that is absorbed into the bloodstream, so Amitiza dosages are restricted for people with liver problems.
Renally impaired patients (kidney disease): no dosage adjustment
Hepatically impaired patients (liver disease)—maximum dose:
Because of pre-existing medical conditions, some people are never given Amitiza. These contraindications include gastrointestinal obstruction, severe diarrhea, and hypersensitivity to Amitiza.
Amitiza gel capsules are taken with food and water twice per day to relieve constipation.
A healthcare provider will indicate how much medicine to take and when to take it. Do not use more than directed.
Swallow the capsule whole. Do not crush, break, or chew it.
Take this medicine with food and water to reduce the chance of nausea.
Store Amitiza in a closed container at room temperature (59° to 86°F) protected from light and extreme temperatures.
Amitiza should begin to affect the colon within one hour of taking a dose. Most people should experience partial constipation relief on the first day. In one clinical study, twice as many people taking lubiprostone had a bowel movement within 24 hours of the first dose (61%) than people who took a placebo (34%). Because Amitiza doses are so tiny, the pharmacokinetics (the effects of the drug in the body) are hard to pin down exactly because drug concentrations in the blood are undetectable.
Some people may experience side effects such as low blood pressure, fainting (syncope), or trouble breathing (dyspnea) on the very first dose. Although these side effects may resolve within three hours, they can happen repeatedly with subsequent doses.
Based on animal studies, healthcare professionals believe lubiprostone is quickly broken down in the stomach and intestines. It is probably not absorbed into the blood. With a half-life of around an hour to an hour and a half, most adverse effects, such as nausea, diarrhea, and trouble breathing (dyspnea) resolve in about three hours.
If a dose is missed, take it as soon as it’s remembered. If it is almost time for the next dose, wait until then and take a regular dose. Do not take extra medicine to make up for a missed dose.
Amitiza can be taken as long as it works and side effects are tolerable. The longest that Amitiza was taken in clinical trials was three months.
Amitiza can be stopped at any time without causing side effects or withdrawal symptoms.
Some people may need to stop taking Amitiza if they experience serious adverse effects such as severe diarrhea, low blood pressure, breathing problems, or loss of consciousness (syncope). Some of these adverse reactions can be serious enough to require hospitalization. Even common side effects such as diarrhea, nausea, vomiting, weakness (asthenia), loose stools, abdominal distension, swelling in the hands or feet (peripheral edema), or flatulence can make Amitiza difficult to take because they sometimes occur after nearly every dose.
If Amitiza cannot be taken for any reason, people with CIC, IBS-C, or OIC can turn to other solutions such as fiber supplements, laxatives, other prosecretory agents similar to Amitiza, ileal bile acid inhibitors, and serotonergic agents.
The maximum dosage for Amitiza is 48 mcg per day.
If too much Amitiza is taken, call a poison helpline or get medical help. People who overdose on Amitiza are likely to experience problems such as nausea, vomiting, dizziness, headache, trouble breathing, fainting, and other common side effects.
Because Amitiza is broken down very quickly in the digestive system, it does not have very many serious drug interactions. Drugs that may cause problems include:
Drugs that slow down intestinal motility such as opioids, tricyclic antidepressants, antidiarrheal medications, anticholinergic drugs, and some antipsychotic medications
The FDA and Takeda Pharmaceuticals, the manufacturer of Amitiza, do not prohibit or caution against drinking alcohol when taking Amitiza. Alcohol may, however, worsen some Amitiza side effects, such as dizziness. Keep in mind that people with CIC, OIC, or IBS are frequently placed on restrictive diets by their doctor or a nutritionist. These diet restrictions or suggestions should rigorously be followed.
Women should get medical advice about the pros and cons of taking Amitiza while pregnant. There is no information on whether Amitiza can harm a human fetus. It is believed to be safe because lubiprostone is minimally absorbed. Animal studies did show, however, that there is an increased risk of fetal loss at very high doses.
Women who are breastfeeding are also advised to be cautious about taking Amitiza. Again, there is minimal information about its effects on milk production or a nursing infant, but healthcare providers believe it is safe because the drug is only minimally absorbed into the body.
Amitiza, Epocrates
Amitiza prescribing information, U.S. National Library of Medicine
Irritable bowel syndrome: Pathogenesis, diagnosis, treatment, and evidence-based medicine, World Journal of Gastroenterology
Lubiprostone compound summary, U.S. National Library of Medicine
Lubiprostone drug summary, Prescriber’s Digital Reference
Lubiprostone in the treatment of chronic idiopathic constipation: An update on health-related quality of life and patient-reported outcomes, Patient Related Outcome Measures
Opioid, StatPearls
Physiology, opioid receptor, StatPearls
Update on the management of chronic idiopathic constipation, AJMC
Josephine Bawab, Pharm.D., graduated from Virginia Commonwealth University School of Pharmacy. She began working in community pharmacy in 2012 and has worked for multiple chain pharmacies since then. She is passionate about helping patients and precepting students. She currently works and resides in Virginia, where she is just a few minutes away from the beach.
...Health education, drug info, wellness & more
Prescription savings vary by prescription and by pharmacy, and may reach up to 80% off cash price. This is a medical discount plan. This is NOT insurance. This program offers you the opportunity to locate providers of various types of medical services who will offer their services to you at discounted rates. The range of discounts for medical or ancillary services provided under the plan will vary depending on the type of provider and service received. You are fully responsible for paying for all health care services but will be entitled to receive a discount from those health care providers in accordance with the specific pre-negotiated discounted fee schedule. This program does not guarantee the quality of the services or procedures offered by the providers. Except for prescription drugs which you will pay directly to the pharmacy at the time of purchase, all other services received through a program provider will be charged to the credit card on file in your member account. The charge will include an administrative fee for use of the program. Towers Administrators LLC is the licensed discount medical plan organization with its administrative office located at 4510 Cox Road, Suite 111, Glen Allen, VA 23060. SingleCare Services, LLC is the marketer of the discount medical plan organization including its website, singlecare.com, with its corporate office located at 99 High Street, Suite 2800, Boston, MA 02110. For additional information, including an up-to-date list of providers, or assistance with any issue related to program membership, please contact member support any time at www.singlecare.com, or by calling toll-free 844-234-3057, 24 hours, 7 days a week (except major holidays). Pharmacy names, logos, brands, and other trademarks are the property of their respective owners.
Blog articles are not medical advice. They are intended for general informational purposes and are not meant to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. If you think you may have a medical emergency, immediately call your physician or dial 911.
© 2025 SingleCare Administrators. All rights reserved
© 2025 SingleCare Administrators. All rights reserved